BPTF inhibitor increases gastric cancer response to Erlotinib by epigenetically regulating c-MYC/PLCG1/pErk axis.
Ontology highlight
ABSTRACT: BPTF inhibitor increases gastric cancer response to Erlotinib by epigenetically regulating c-MYC/PLCG1/pErk axis.
PROVIDER: PRJNA823552 | ENA |
REPOSITORIES: ENA
ACCESS DATA